CasanovaMFWalkerLCWhitehousePJPriceDL. Abnormalities of the nucleus basalis Down syndrome. Ann Neurol1985;18: 310–3.
2.
KishnaniPSSullivanJAWalterBKSpiridiqliozziGADoraiswamyPMKrishnanKR. Cholinergic therapy for Down's syndrome. Lancet1999;353: 1064–5.
3.
Hemingway-EltomeyJMLernerAJ. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome (letter). Am J Psychiatry1999;156:1470.
4.
CiprianiGBianchettiATrabucchiM.Donepezil use in the treatment of dementia associated with Down syndrome (letter). Arch Neurol2003;60:292.
5.
MiharaMOhnishiAKamakuraHTomonoYHasegawaJYamazakiKPharmacokinetics of E2020, a new compound for Alzheimer's disease in healthy male volunteers. Int J Clin Pharmacol Ther Toxicol1993;31: 223–9.
